One and done: Reasons principal investigators conduct only one FDA-regulated drug trial

One and done: Reasons principal investigators conduct only one FDA-regulated drug trial

Concerns have been raised over the high turnover rate for clinical investigators. Using the U.S. Food and Drug Administration's (FDA) Bioresearch Monitoring Information System database, we conducted an online survey to identify factors that affect principal investigators' (PIs) decisions t...

Full description

Bibliographic Details
Main Authors: Amy Corneli, PhD, MPH, Christine Pierre, RN, Terri Hinkley, RN, BScN, MBA, CCRC, Li Lin, MS, Christopher B. Fordyce, MD, MSc, Gerrit Hamre, MA, Matthew T. Roe, MD, MHS
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Contemporary Clinical Trials Communications
Subjects:
FDA
Drug trials
Investigator turnover
Attrition
Physician-investigator
Online Access:http://www.sciencedirect.com/science/article/pii/S245186541630093X

Internet

http://www.sciencedirect.com/science/article/pii/S245186541630093X

Similar Items